Non alcoholic fatty liver disease. ?????? ??? ??? ??? ?????
Conditions
Interventions
Intervention 1: Intervention group: The training protocol includes a combination of resistance training and high-intensity interval training (HIIT) for 12 weeks, three sessions per week, two sessions
Sponsors
Bo Ali Sina University, Hamedan
Eligibility
Sex/Gender
Male
Age
30 Years to 50 Years
Inclusion criteria
Inclusion criteria: Having grade two and three non-alcoholic fatty liver disease
Exclusion criteria
Exclusion criteria: Being athletes Smokers Having diabetes Having high blood pressure Chronic diseases Cardiovascular disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver enzymes (ALT, AST, ALP). Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: Before and after the intervention, blood samples will be measured with diagnostic kits for enzymes in the laboratory.;Omentin-1. Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: ELISA method.;Fetuin-B. Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: ELISA method.;Ultrasound of the liver. Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: Using an ultrasound device, the intervention will be performed before and after 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar(FBS). Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: ELISA method.;Triglycerides (TG). Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: ELISA method.;Cholesterol(CHO). Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: ELISA method.;Low-density lipoprotein cholesterol (LDL). Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: ELISA method.;High-density lipoprotein cholesterol (HDL). Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: ELISA method.;Waist-Hip Ratio (WHR). Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: WHR is evaluated using Anya's three-dimensional body analyzer device, before and after the intervention, and then the final information is taken from the device.;Body Fat Percentage. Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: The percentage of body fat is evaluated using Anya's 3D body analyzer before and after the intervention, and then the final information is taken from the device.;Vo2max. Timepoint: The time period of outcome measurement will be implemented before the intervention and 12 weeks after the intervention. Method of measurement: The maximum oxygen consumption is measured by the Bruce test before and after the intervention. This Bruce test is performed on a treadmill. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ali Heydarianpour
Boali Sina University, Hamedan
Outcome results
None listed